These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2707475)

  • 1. Effects of a defibrotide-heparin combination on some measures of haemostasis in healthy volunteers.
    Pogliani EM; Salvatore M; Fowst C; Girardello R; Marelli C
    J Int Med Res; 1989; 17(1):36-40. PubMed ID: 2707475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defibrotide affects the anticoagulant and lipase-releasing activities of heparin.
    Porta R; Pescador R; Mantovani M; Prino G
    Haemostasis; 1990; 20(6):347-56. PubMed ID: 2099323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis with defibrotide: effects on coagulation parameters.
    Filimberti E; Cinotti S; Salvadori M; Amato M; Longo G; Nazzari M; Morfini M
    Int J Artif Organs; 1992 Oct; 15(10):590-4. PubMed ID: 1428206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defibrotide reduces monocyte PAI-2 and procoagulant activity.
    Abbate R; Gori AM; Martini F; Attanasio M; Comeglio P; Giusti B; Zarone N; Francalanci I; Prisco D; Gensini GF
    Semin Thromb Hemost; 1995; 21(2):245-50. PubMed ID: 7660147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
    Echart CL; Graziadio B; Somaini S; Ferro LI; Richardson PG; Fareed J; Iacobelli M
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):627-34. PubMed ID: 19809307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic effect and clinical potential of defibrotide.
    Ulutin ON
    Semin Thromb Hemost; 1993; 19 Suppl 1():186-91. PubMed ID: 8362266
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance.
    Violi F; Ferro D; Saliola M; Quintarelli C; Basili S; Balsano F
    Eur J Clin Pharmacol; 1992; 42(4):379-83. PubMed ID: 1516602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of anti-Xa activity during combined defibrotide-heparin administration in hemodialysis.
    Buccianti G; Valenti G; Lorenz M; Cresseri D; Strada E; Nazzari M
    Int J Artif Organs; 1990 Jul; 13(7):416-20. PubMed ID: 2401580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of deep venous thrombosis in orthopedic surgery: effects of defibrotide.
    Zanasi R; Fioretta G; Ciocia G; Bergonzi M
    Clin Ther; 1988; 10(4):350-7. PubMed ID: 3079005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders.
    Palmer KJ; Goa KL
    Drugs; 1993 Feb; 45(2):259-94. PubMed ID: 7681375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological changes in carotid arteries of rabbits induced by defibrotide infusion.
    Bilsel S; San T; Erşahin C; Moini H; Okar I; Emerk K
    Thromb Res; 1994 Dec; 76(5):433-40. PubMed ID: 7900091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defibrotide is equipotent to urokinase in stimulating arterial and venous thrombolysis.
    Grodzińska L; König E; Schrör K
    Pharmacol Res Commun; 1987 Sep; 19(9):609-15. PubMed ID: 3432326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology and mode of action of a new antithrombotic compound: Defibrotide.
    Ulutin ON; Cizmeci G; Balkuv-Ulutin S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):177-80. PubMed ID: 2459016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defibrotide in extracorporeal circulation on healthy rabbits.
    Marsili M; Lorenzi P; Librenti M; Doni L; Benassai C; Martini E; Fabbri LP; Cinotti S; Morfini M; Boncinelli S
    Int J Artif Organs; 1989 Dec; 12(12):749-54. PubMed ID: 2613355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.
    Carlo-Stella C; Di Nicola M; Magni M; Longoni P; Milanesi M; Stucchi C; Cleris L; Formelli F; Gianni MA
    Cancer Res; 2002 Nov; 62(21):6152-7. PubMed ID: 12414641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant and antithrombotic effects of combinations of defibrotide with heparins and other antithrombotic agents in an animal thrombosis model.
    Giedrojc J; Breddin HK
    Thromb Res; 1991 Jul; 63(1):99-110. PubMed ID: 1948825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated view of the activities of defibrotide.
    Pescador R; Porta R; Ferro L
    Semin Thromb Hemost; 1996; 22 Suppl 1():71-5. PubMed ID: 8807733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the fibrinolytic activity of defibrotide fractions.
    Hizal N; Bilsel S; Emerk K
    Gen Pharmacol; 1994 Dec; 25(8):1617-20. PubMed ID: 7721037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.